BRAF and melanoma: Conversely, resistance to mitogen-activated protein kinase (MAPK) pathway inhibitors has generally been associated with increased FAO in BRAF mutated melanoma cells and this agreement with our finding which decreases these free fatty acids due to the increase of fatty acids oxidation [15].